The Health and Human Services Department would look a lot different, and spend a lot less money, under a plan the White House ...

Every healthcare company claims to be working in the patient's best interest, and yet prices only seem to rise.

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

President Donald Trump issued an executive order (EO) on May 12, 2025 to address the high cost of prescription drugs in the ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...

McDermott gathered more than 100 health and life sciences innovators, investors, business leaders and advisers in Paris for our ...

With thousands of gene and cell therapies in the pipeline, health systems should make sure they are for these drugs, which can cost millions per dose, according to the American Society of ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

President Donald Trump’s proposal to peg US drug prices to those paid abroad includes granting the FDA legal authority to ...

Federal agencies are seeking public feedback on how to improve price transparency around prescription drugs and boost ...